• Effector Caspases Drive Autophagy and DNA Repair in Breast C

  2026-05-07

  This study uncovers a non-apoptotic role for caspase 3 and caspase 7 in promoting cytoprotective autophagy and facilitating DNA damage responses under non-lethal stress in human breast cancer cells. These findings broaden our understanding of cell stress adaptation mechanisms and open new avenues for targeted cancer therapy research.

• Pemetrexed Disodium: Mechanistic Insights and Precision Onco

  2026-05-07

  Explore how pemetrexed disodium, a potent antifolate antimetabolite, advances cancer chemotherapy research through multi-enzyme inhibition and evidence-based applications in tumor models. This article bridges molecular pharmacology with practical assay design, providing unique, actionable insights for researchers.

• AO/PI Staining Solution: Precision Fluorescent Cell Counting

  2026-05-06

  AO/PI Staining Solution empowers researchers to achieve accurate, interference-free live/dead cell discrimination in fluorescence-based assays. Its dual fluorescent DNA dye system surpasses traditional viability methods, streamlining workflows for disease modeling and apoptosis studies.

• Epinephrine Bitartrate: Applied Workflows in Adrenergic Rese

  2026-05-06

  Unlock reproducible, high-sensitivity adrenergic assays with Epinephrine Bitartrate. This guide translates cutting-edge pharmacokinetic insights and real-world troubleshooting into actionable workflows for cardiovascular and neurobiology research.

• Triacetin in Translational Research: Mechanisms and Next Ste

  2026-05-05

  This article explores Triacetin’s mechanistic foundations, experimental validation, and translational potential as a lipid-related biochemical reagent. Integrating evidence-backed guidance and strategic context, it positions APExBIO’s Triacetin as a transformative tool for researchers targeting glioblastoma, metabolic regulation, and anti-adipogenesis. The discussion bridges molecular insight with protocol guidance, critically referencing peer-reviewed breakthroughs while mapping future directions for epigenetic and metabolic research.

• HyperScript III RT SuperMix: High-Fidelity cDNA Synthesis fo

  2026-05-05

  HyperScript III RT SuperMix enables high-yield, accurate cDNA synthesis for gene expression analysis by qPCR. Its advanced enzyme formulation ensures efficient reverse transcription of low-concentration and high-GC RNA templates, while integrated gDNA wiper mix minimizes genomic contamination. This product supports reproducible results in translational oncology and precision biomarker research.

• JC-1: Optimizing Mitochondrial Membrane Potential Assays

  2026-05-04

  JC-1, or 5,6-dichloro-2-[(E)-3-(5,6-dichloro-1,3-diethylbenzimidazol-3-ium-2-yl)prop-2-enylidene]-1,3-diethylbenzimidazole iodide, delivers dual-emission, ratiometric analysis for mitochondrial membrane potential in live-cell models. By leveraging JC-1 from APExBIO, researchers can enhance apoptosis detection, investigate mitochondrial dysfunction, and streamline troubleshooting in high-impact cellular bioenergetics studies.

• Proliferation Tracing in Mouse Models Reveals Mechanisms of

  2026-05-04

  This study introduces a dual recombinase genetic system in MMTV-PyMT transgenic mice to precisely trace and ablate proliferating breast cancer cells, enabling robust modeling of tumor relapse. Single-cell transcriptomic analyses uncover the cellular and microenvironmental heterogeneity driving recurrence, providing a valuable resource for mechanistic studies and therapeutic testing.

• Z-IETD-FMK: Specific Caspase-8 Inhibitor for Apoptosis Resea

  2026-05-03

  Z-IETD-FMK (Benzyloxycarbonyl-Ile-Glu(OMe)-Thr-Asp(OMe)-fluoromethylketone) is a potent, selective inhibitor of caspase-8, central to apoptosis and T cell activation studies. Its irreversible mechanism enables precise modulation of cell death pathways without affecting resting immune cells. APExBIO provides validated protocols for research use, supporting advanced immune cell signaling and apoptosis research with robust benchmarks.

• HLTP1 Peptide Attenuates Hepatic Ischemia-Reperfusion Injury

  2026-05-02

  This study identifies a novel human-derived peptide, HLTP1, that significantly reduces hepatic ischemia-reperfusion injury (HIRI) by inhibiting Jun N-terminal kinase (JNK) phosphorylation and apoptosis in experimental models. The findings offer mechanistic insight and a promising foundation for therapeutic strategies targeting liver transplant complications.

• Dual SMAD/Wnt Inhibition Enables Efficient iPSC-RGC Differen

  2026-05-02

  This study introduces a chemically defined protocol for efficiently differentiating human induced pluripotent stem cells (iPSCs) into retinal ganglion cells (RGCs) by dual inhibition of SMAD and Wnt pathways. The method achieves high purity and reproducibility without genetic manipulation, offering a robust platform for modeling glaucoma and advancing neurodegenerative disease research.

• Ionomycin Calcium Salt: Precision Calcium Ionophore for Canc

  2026-05-01

  Ionomycin calcium salt empowers researchers with unrivaled control over intracellular Ca2+ flux, enabling high-fidelity modeling of calcium-dependent cell signaling and apoptosis. Its validated anti-cancer actions, especially in bladder cancer models, set it apart as a gold-standard calcium ionophore for translational and mechanistic workflows.

• Multi-Omics Reveals ARID1A-Driven Resistance in Melanoma

  2026-04-30

  This study employs integrative multi-omics to dissect early and acquired resistance mechanisms to BRAF/MAPK inhibition in melanoma, focusing on the role of ARID1A loss. The findings highlight key signaling nodes and transcriptional rewiring underpinning resistance, offering new targets for research into more durable melanoma therapies.

• RNA Pol II Inhibition Triggers Apoptosis Beyond Transcriptio

  2026-04-30

  Harper et al. (2025) demonstrate that inhibition of RNA polymerase II (Pol II) induces apoptosis through an active signaling pathway, independent of global transcriptional shutdown. This finding redefines cell death mechanisms in response to transcriptional stress and offers new experimental avenues for apoptosis and inflammation research.

• Tunicamycin as a Molecular Probe: Decoding ER Stress Pathway

  2026-04-29

  Explore how Tunicamycin, a potent N-glycosylation inhibitor, is illuminating new frontiers in ER stress pathway research and inflammation suppression. Distinct from protocol-driven guides, this article delivers a mechanistic, cross-disciplinary analysis with practical assay insights.

421 records 17/29 page Previous Next First page 上5页 1617181920 下5页 Last page